• Culture, Acid-Fast Bacilli, Urine
  • Clostridium difficile (C. Diff) by Molecular Method
  • CDKN1C Gene Mutation Analysis
  • Protriptyline, Urine
  • MSK-IMPACTâ„¢, Solid Organ Gene Cancer Panel
  • Fluconazole, Urine
  • B and T Cell Gene Rearrangement, Blood
  • B-cell Activating Factor Receptor (BAFF-R) Gene Mutation Analysis
  • PML-RARA (Promyelocytic Leukemia/Retinoic Acid Receptor Alpha) Translocation, t(15;17) Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Additional Testing
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.